Holen Sie sich die Stockscreener-App
79.02
0.28%
-0.22
Handel nachbörslich:
79.02
Schlusskurs vom Vortag:
$79.24
Offen:
$79.24
24-Stunden-Volumen:
751.11K
Relative Volume:
0.72
Marktkapitalisierung:
$13.71B
Einnahmen:
$8.31B
Nettoeinkommen (Verlust:
$379.00M
KGV:
36.58
EPS:
2.16
Netto-Cashflow:
$385.00M
1W Leistung:
-1.79%
1M Leistung:
-7.68%
6M Leistung:
+0.98%
1J Leistung:
+19.85%
1-Tages-Spanne:
$78.38
$79.62
1-Wochen-Bereich:
$78.38
$80.97
52-Wochen-Spanne:
$60.70
$88.20
Solventum Corp Stock (SOLV) Company Profile
Firmenname
Solventum Corp
Sektor
Telefon
651-733-1110
Adresse
C/O 3M COMPANY, ST. PAUL
Vergleichen Sie SOLV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SOLV
Solventum Corp
|
79.02 | 13.74B | 8.31B | 379.00M | 385.00M | 2.16 |
|
ISRG
Intuitive Surgical Inc
|
561.98 | 200.77B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
194.94 | 55.29B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
77.60 | 38.71B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.81 | 35.16B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
40.62 | 33.06B | 27.43B | 1.27B | 1.01B | 1.5829 |
Solventum Corp Stock (SOLV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-12-02 | Hochstufung | BTIG Research | Neutral → Buy |
| 2025-10-01 | Eingeleitet | UBS | Neutral |
| 2025-09-11 | Eingeleitet | Jefferies | Hold |
| 2025-07-15 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2025-07-01 | Hochstufung | Argus | Hold → Buy |
| 2025-06-06 | Eingeleitet | KeyBanc Capital Markets | Sector Weight |
| 2025-05-19 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2024-12-04 | Eingeleitet | Mizuho | Neutral |
| 2024-10-08 | Eingeleitet | Stifel | Buy |
| 2024-10-07 | Eingeleitet | Piper Sandler | Neutral |
| 2024-09-26 | Eingeleitet | Wolfe Research | Peer Perform |
| 2024-09-05 | Eingeleitet | BTIG Research | Neutral |
| 2024-06-24 | Eingeleitet | Argus | Hold |
| 2024-05-30 | Eingeleitet | Goldman | Sell |
| 2024-05-10 | Eingeleitet | BofA Securities | Neutral |
| 2024-04-10 | Eingeleitet | Morgan Stanley | Equal-Weight |
| 2024-04-08 | Eingeleitet | Wells Fargo | Equal Weight |
| 2024-04-02 | Eingeleitet | Edward Jones | Hold |
Alle ansehen
Solventum Corp Aktie (SOLV) Neueste Nachrichten
Solventum Advances Orthodontic Treatment by Helping Shape Modern Orthodontics - Digital Journal
Bioprocess Filtration Global Markets Report 2025-2030, Profiles of Leading PlayersDanaher, Merck, Sartorius, Solventum, and RepligenResearchAndMarkets.com - FinancialContent
Solventum Corp. stock falls Wednesday, underperforms market - MarketWatch
Solventum to Acquire Acera Surgical in $725 Mn Deal to Boost Regenerative Wound-Care Portfolio - Digital Health News
Key sale, acquisition helped 3M spinoff, Solventum, turn around in 2025 - Star Tribune
Are Medical Stocks Lagging Solventum Corporation (SOLV) This Year? - Yahoo Finance
Harbor Capital Advisors Inc. Has $1.31 Million Stake in Solventum Corporation $SOLV - MarketBeat
Solventum Corporation (NYSE:SOLV) Receives Average Recommendation of "Hold" from Brokerages - MarketBeat
Solventum Corporation (NYSE:SOLV) Given Consensus Rating of "Hold" by Analysts - MarketBeat
SOLV Acquires Acera Surgical to Expand Advanced Wound Care Portfolio - sharewise.com
Strong Tower Advisory Services Buys 16,851 Shares of Solventum Corporation $SOLV - MarketBeat
Solventum Completes Acquisition of Acera Surgical - The Malaysian Reserve
Solventum completes acquisition of Acera Surgical for $725 million By Investing.com - Investing.com Nigeria
Solventum Closes Acquisition of Acera Surgical - marketscreener.com
Solventum completes Acera Surgical acquisition - MassDevice
Solventum completes acquisition of Acera Surgical for $725 million - Investing.com India
Solventum is the top performing healthcare supplies stock YTD - MSN
Solventum is the top performing healthcare supplies stock YTD (SOLV:NYSE) - Seeking Alpha
Is Solventum stock outperforming the Nasdaq? - MSN
How Investors Are Reacting To Solventum (SOLV) Expert Guidance Expanding Use Of Prevena ciNPT Dressings - simplywall.st
Wedge Capital Management L L P NC Sells 64,461 Shares of Solventum Corporation $SOLV - MarketBeat
Will Expert Backing for ciNPT Prevena Dressings Redefine Solventum's (SOLV) Advanced Wound Care Edge? - Yahoo Finance
Why retail investors pile into Solventum Corporation stock2025 Top Decliners & Stepwise Swing Trade Plans - Улправда
Is Solventum Stock Underperforming the S&P 500? - MSN
Solventum (SOLV): Assessing Valuation After New Clinical Guidance Expands Prevena Therapy’s Surgical Use - simplywall.st
Argus Research Adjusts Solventum Price Target to $100 From $90, Maintains Buy Rating - marketscreener.com
Assenagon Asset Management S.A. Boosts Position in Solventum Corporation $SOLV - MarketBeat
Global Expert Panel Publishes New Recommendations on Advanced Use of Closed Incision Negative Pressure Therapy - Finviz
New surgery guidelines expand use of vacuum dressings to protect incisions - Stock Titan
Piper Sandler names Solventum stock its 2026 top idea, maintains $98 target - Investing.com Nigeria
Solventum Corporation reflects on transformative year - MSN
Solventum Earns Diamond Level HIRC Resiliency Badge, Demonstrating Best-In-Class Supply Chain Strength - Finviz
Solventum Corp. stock falls Tuesday, underperforms market - MarketWatch
Solventum earns diamond level supply chain certification for healthcare By Investing.com - Investing.com Australia
Solventum earns diamond level supply chain certification for healthcare - Investing.com
3M at a Crossroads: Strategic Moves and Persistent Headwinds - AD HOC NEWS
Solventum Corporation Reflects on Transformative Year - TipRanks
Wells Fargo Adjusts Price Target on Solventum to $86 From $72, Maintains Equalweight Rating - marketscreener.com
Solventum Corp Reflects on Year of Growth and Transformation - TradingView — Track All Markets
Is Solventum Stock Outperforming the Nasdaq? - Yahoo Finance
Solventum Corp. stock falls Monday, underperforms market - MarketWatch
Finanzdaten der Solventum Corp-Aktie (SOLV)
Umsatz
Nettogewinn
Free Cashflow
ENV
Solventum Corp-Aktie (SOLV) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| 3M CO | 10% Owner |
Aug 15 '25 |
Sale |
73.45 |
8,800,000 |
646,360,000 |
25,569,190 |
| COX CARRIE SMITH | Director |
May 13 '25 |
Option Exercise |
0.00 |
5,148 |
0 |
5,148 |
| Hanson Bryan C | Chief Executive Officer |
May 13 '25 |
Option Exercise |
0.00 |
34,315 |
0 |
75,108 |
| Harris Bernard A Jr | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Edwards Shirley Ann | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Wilcox Mary T | Chief Accounting Officer |
May 13 '25 |
Option Exercise |
0.00 |
2,375 |
0 |
2,375 |
| DeVore Susan D. | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| ALBAN CARLOS | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
| Harrington Paul S | Chief Supply Chain Officer |
May 13 '25 |
Option Exercise |
0.00 |
3,959 |
0 |
11,220 |
| Wendell Amy McBride | Director |
May 13 '25 |
Option Exercise |
0.00 |
3,564 |
0 |
3,564 |
1.04%
0.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):